Home - Products - Others - Other Targets - Cholecystokinin Octapeptide (2-8) (desulfated)

Cholecystokinin Octapeptide (2-8) (desulfated)

CAS No. 47910-79-2

Cholecystokinin Octapeptide (2-8) (desulfated)( ——— )

Catalog No. M41025 CAS No. 47910-79-2

CCK (27-33) is the C-terminal heptapeptide of cholecystokinin (CCK).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cholecystokinin Octapeptide (2-8) (desulfated)
  • Note
    Research use only, not for human use.
  • Brief Description
    CCK (27-33) is the C-terminal heptapeptide of cholecystokinin (CCK).
  • Description
    CCK (27-33) is the C-terminal heptapeptide of cholecystokinin (CCK).
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    47910-79-2
  • Formula Weight
    948.14
  • Molecular Formula
    C45H57N9O10S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Schiller PW, et al. Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. Biochem Biophys Res Commun. 1978 Dec 29;85(4):1332-8. ?
molnova catalog
related products
  • HIF-1 alpha 556-574

    HIF-1 alpha (556-574) is a hypoxia-inducible factor-1 19-mer fragment. HIF-1 functions as master regulator of response to oxygen homeostasis. Hypoxia-induced gene expression is initiated when HIF-1subunit is stabilized in response to a lack of oxygen. This part of HIF-1 binds to the von Hippel-Lindau factor (VHL) an E3 ubiquitin ligase, and the proline 564 is absolutely vital to the binding process.

  • Psoralidin

    Psoralidin inhibits Akt phosphorylation and phosphatidylinositol 3-kinase activation and transcriptionally.

  • 2-Chlorophenothiazin...

    It is used as the intermediate of Chlorpromazine hydrochloride.